{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:56:53Z","timestamp":1760061413012},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ijantimicag.2005.07.016","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T07:13:45Z","timestamp":1129878825000},"page":"403-407","source":"Crossref","is-referenced-by-count":6,"title":["Time\u2013kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion for treatment of septicaemic melioidosis"],"prefix":"10.1016","volume":"26","author":[{"given":"Cheardchai","family":"Soontornpas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumarn","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malyn","family":"Chulasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Busba","family":"Chindavijak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piroon","family":"Mootsikapun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.07.016_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0001-706X(99)00062-5","article-title":"Recent advances in the treatment of severe melioidosis","volume":"74","author":"Chaowagul","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.35.3.484","article-title":"Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics","volume":"35","author":"Sookpranee","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib3","first-page":"88","article-title":"In vitro antimicrobial susceptibilities and exoenzymed production of two biotypes of Burkholderia pseudomallei","volume":"18","author":"Lulitanond","year":"2001","journal-title":"J Infect Dis Antimicrob Agent"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing in mice and man","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/AAC.40.3.691","article-title":"Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infection","volume":"40","author":"Benko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/43.2.309","article-title":"Continuous infusion ceftazidime in intensive care: a randomized controlled trial","volume":"43","author":"Lipman","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/40.1.125","article-title":"Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics","volume":"40","author":"Vinks","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0924-8579(01)00329-6","article-title":"Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia","volume":"17","author":"Nicolau","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-3156.2004.01244.x","article-title":"Out of hospital treatment of patients with melioidosis using ceftazidime in 24h elastomeric infusors, via peripherally inserted central catheters","volume":"9","author":"Huffam","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2125.2000.00179.x","article-title":"Pharmacokinetic\u2013pharmacodynamic evaluation of ceftazidime continuous infusion vs. intermittent bolus injection in septicaemic melioidosis","volume":"49","author":"Angus","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/AAC.38.5.931","article-title":"Killing of Pseudomonas aeruginosa during continuous infusion and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model","volume":"38","author":"Mouton","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib12","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dkg467","article-title":"Time\u2013kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion","volume":"52","author":"Piccoli","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/33.1.145","article-title":"Susceptibility of Pseudomonas pseudomallei to some newer \u03b2-lactam antibiotics and antibiotic combinations using time\u2013kill studies","volume":"33","author":"Smith","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib14","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution and antimicrobial susceptibility test for bacteria that grow aerobically. 5th ed. Approved standard M7-A5. Wayne, PA: NCCLS; 2000."},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-7012(00)00241-4","article-title":"How to optimize the drop plate method for enumerating bacteria","volume":"44","author":"Herigstad","year":"2001","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004300050110","article-title":"Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis","volume":"188","author":"Haussler","year":"1999","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2005.07.016_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00003088-199835050-00004","article-title":"Continuous infusion of \u03b2-lactam antibiotics","volume":"35","author":"MacGowan","year":"1998","journal-title":"Clin Pharmacokinet"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T18:03:03Z","timestamp":1554228183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905002268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0924857905002268"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.07.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}